Vanderbilt-Ingram Cancer Center / Vanderbilt University — Nashville, Tennessee

Vanderbilt-Ingram Cancer Center / Vanderbilt University is a clinical research site located in Nashville, Tennessee, United States 37215.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt-Ingram Cancer Center / Vanderbilt University has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML), Squamous Cell Carcinoma.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt-Ingram Cancer Center / Vanderbilt University?

Vanderbilt-Ingram Cancer Center / Vanderbilt University has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt-Ingram Cancer Center / Vanderbilt University conducted?

Vanderbilt-Ingram Cancer Center / Vanderbilt University has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML), Squamous Cell Carcinoma.

Is Vanderbilt-Ingram Cancer Center / Vanderbilt University accredited by Crixeo Health?

Vanderbilt-Ingram Cancer Center / Vanderbilt University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt-Ingram Cancer Center / Vanderbilt University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.